{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:48Z","timestamp":1790613828542,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.tjog.2024.01.038","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:38:38Z","timestamp":1730306318000},"page":"874-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and sonographic risk factors for developing pre-eclampsia refractory to aspirin prophylaxis"],"prefix":"10.1016","volume":"63","author":[{"given":"Chia-Chen","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie-Pein","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tjog.2024.01.038_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"issue":"6","key":"10.1016\/j.tjog.2024.01.038_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.tjog.2024.01.038_bib3","first-page":"861","article-title":"Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis","volume":"98","author":"Coomarasamy","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2S","key":"10.1016\/j.tjog.2024.01.038_bib4","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.tjog.2024.01.038_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1016\/j.tjog.2024.01.038_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.tjog.2024.01.038_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.tjog.2024.01.038_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/uog.2814","article-title":"Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome","volume":"28","author":"Gomez","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.tjog.2024.01.038_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pd.2930","article-title":"Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation","volume":"32","author":"Napolitano","year":"2012","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.tjog.2024.01.038_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/10641955.2016.1181180","article-title":"Etiopathogenesis, prediction, and prevention of preeclampsia","volume":"35","author":"Correa","year":"2016","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"10.1016\/j.tjog.2024.01.038_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"2 Pt 1","key":"10.1016\/j.tjog.2024.01.038_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.tjog.2024.01.038_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.tjog.2024.01.038_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011801","article-title":"Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)","volume":"6","author":"O'Gorman","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.tjog.2024.01.038_bib15","doi-asserted-by":"crossref","first-page":"585 e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.tjog.2024.01.038_bib16","first-page":"25","article-title":"Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998-2002","volume":"47","author":"Hsieh","year":"2006","journal-title":"Acta Paediatr Taiwanica"},{"issue":"1","key":"10.1016\/j.tjog.2024.01.038_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.tjog.2024.01.038_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 Weeks' gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tjog.2024.01.038_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijgo.13302","article-title":"Role of second-trimester uterine artery Doppler indices in the prediction of adverse pregnancy outcomes in a low-risk population","volume":"151","author":"Adefisan","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.tjog.2024.01.038_bib20","first-page":"1","article-title":"Effects of early aspirin therapy on utero-placental hemodynamics in patients at risk of preeclampsia","author":"Malah","year":"2020","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.tjog.2024.01.038_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/AOG.0000000000000118","article-title":"First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation","volume":"123","author":"Block-Abraham","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.tjog.2024.01.038_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/uog.23668","article-title":"ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis","volume":"58","author":"Shen","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.tjog.2024.01.038_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/uog.18992","article-title":"Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis","volume":"52","author":"Baschat","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9403","key":"10.1016\/j.tjog.2024.01.038_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Whoe","year":"2004","journal-title":"Lancet"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455924002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455924002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T16:26:04Z","timestamp":1730910364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455924002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1028455924002365"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2024.01.038","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and sonographic risk factors for developing pre-eclampsia refractory to aspirin prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2024.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}